Mattias Hammarström

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Forskningsbeskrivning

Head of Operations KARMA project

Artiklar

Article: INTERNATIONAL JOURNAL OF CANCER. 2024

Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change.

Gabrielson M; Hammarström M; Bergqvist J; Lång K; Rosendahl AH; Borgquist S; Hellgren R; Czene K; Hall P
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023;115(11):1310-1317

Prediction of breast cancer risk for sisters of women attending screening.

Mao X; He W; Eriksson M; Lindström LS; Holowko N; Bajalica-Lagercrantz S; Hammarström M; Grassmann F; Humphreys K; Easton D; Hall P; Czene K
Article: BRITISH JOURNAL OF CANCER. 2023;129(1):61-71

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women.

Hammarström M; Gabrielson M; Crippa A; Discacciati A; Eklund M; Lundholm C; Bäcklund M; Wengström Y; Borgquist S; Bergqvist J; Eriksson M; Tapia J; Czene K; Hall P
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;152(11):2362-2372

Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy women.

Gabrielson M; Hammarström M; Bäcklund M; Bergqvist J; Lång K; Rosendahl AH; Borgquist S; Hellgren R; Czene K; Hall P
Article: ONCOLOGIST. 2022;27(7):e601-e603

Time to Mammographic Density Decrease After Exposure to Tamoxifen.

Bäcklund M; Eriksson M; Hammarström M; Thoren L; Bergqvist J; Margolin S; Hellgren R; Wengström Y; Gabrielson M; Czene K; Hall P
Article: ONCOLOGIST. 2022;27(7):e597-e600

Topical Endoxifen for Mammographic Density Reduction-A Randomized Controlled Trial.

Bäcklund M; Eriksson M; Gabrielson M; Hammarström M; Quay S; Bergqvist J; Hellgren R; Czene K; Hall P
Article: ANNALS OF ONCOLOGY. 2021;32(10):1286-1293

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial.

He W; Eriksson M; Eliasson E; Grassmann F; Bäcklund M; Gabrielson M; Hammarström M; Margolin S; Thorén L; Wengström Y; Borgquist S; Hall P; Czene K
Article: LAKARTIDNINGEN. 2021;118:21092

[It is time for individual breast cancer prevention].

Hall P; Hammarström M; Hellgren R
Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(17):1899-1908

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.

Eriksson M; Eklund M; Borgquist S; Hellgren R; Margolin S; Thoren L; Rosendahl A; Lång K; Tapia J; Bäcklund M; Discacciati A; Crippa A; Gabrielson M; Hammarström M; Wengström Y; Czene K; Hall P
Article: BMC CANCER. 2020;20(1):247

European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.

Rainey L; van der Waal D; Jervaeus A; Donnelly LS; Evans DG; Hammarström M; Hall P; Wengström Y; Broeders MJM
Article: PSYCHO-ONCOLOGY. 2019;28(5):1056-1062

Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.

Rainey L; Jervaeus A; Donnelly LS; Evans DG; Hammarström M; Hall P; Wengström Y; Broeders MJM; van der Waal D
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2017;46(6):1740-1741g

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA).

Gabrielson M; Eriksson M; Hammarström M; Borgquist S; Leifland K; Czene K; Hall P

Anställningar

Teamchef, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2022-
Doktorand, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2019-2025

Forskningsbeskrivning

Artiklar

Anställningar

Nyheter från KI

Kalenderhändelser från KI